Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcriptional enhanced associate domain protein 4 (TEAD4) mRNA is the transcript encoding a key transcription factor within the Hippo signaling pathway. The TEAD4 protein acts as a primary nuclear partner for the transcriptional co-activators YAP and TAZ, facilitating the expression of genes that promote cell survival, proliferation, and stemness (PMID: 31434659). In various malignancies, TEAD4 is frequently overexpressed or hyperactivated, contributing to tumor progression, metastasis, and resistance to therapy (PMID: 30217974). Targeting TEAD4 at the mRNA level using antisense oligonucleotides or RNA interference offers a strategy to deplete the protein product, which is traditionally considered difficult to target with small molecules due to its lack of conventional binding pockets. This approach aims to disrupt the YAP/TAZ-TEAD transcriptional output, thereby inhibiting oncogenic signaling in Hippo-deficient or YAP/TAZ-driven cancers. By reducing the levels of TEAD4 mRNA, researchers hope to suppress the epithelial-mesenchymal transition and increase the sensitivity of cancer cells to existing treatments (NCBI Gene ID: 7004).
RNA interference (RNAi) or RNase H-mediated degradation of the mRNA transcript to prevent translation into the TEAD4 protein, thereby inhibiting the formation of the YAP/TAZ-TEAD transcriptional complex.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcriptional enhanced associate domain protein 4 mRNA (TEAD4 mRNA).